about
Diagnostic performance of an Aspergillus-specific nested PCR assay in cerebrospinal fluid samples of immunocompromised patients for detection of central nervous system aspergillosisCoregulation of HIV-1 dependency factors in individuals heterozygous to the CCR5-delta32 deletion.Aspergillus PCR-based investigation of fresh tissue and effusion samples in patients with suspected invasive Aspergillosis enhances diagnostic capabilitiesMelting point assay for the JAK2 V617F mutation, comparison with amplification refractory mutation system (ARMS) in diagnostic samples, and implications for daily routine.Development of novel PCR assays to detect azole resistance-mediating mutations of the Aspergillus fumigatus cyp51A gene in primary clinical samples from neutropenic patients.Coinfection of Pneumocystis jirovecii and invasive pulmonary aspergillosis in an immunocompromised patient: a diagnostic challenge.Norovirus gastroenteritis causes severe and lethal complications after chemotherapy and hematopoietic stem cell transplantation.Low-dose liposomal amphotericin B in the prevention of invasive fungal infections in patients with prolonged neutropenia: results from a randomized, single-center trial.Expression of Wilms' tumor gene 1 at different stages of acute myeloid leukemia and analysis of its major splice variants.In acute promyelocytic leukemia (APL) low BAALC gene expression identifies a patient group with favorable overall survival and improved relapse free survival.Therapy with antifungals decreases the diagnostic performance of PCR for diagnosing invasive aspergillosis in bronchoalveolar lavage samples of patients with haematological malignancies.Quantitative real-time RT-PCR detects elevated Wilms tumor gene (WT1) expression in autologous blood stem cell preparations (PBSCs) from acute myeloid leukemia (AML) patients indicating contamination with leukemic blastsDiagnosing pulmonary aspergillosis in patients with hematological malignancies: a multicenter prospective evaluation of an Aspergillus PCR assay and a galactomannan ELISA in bronchoalveolar lavage samplesTopotecan and ifosfamide systemic chemotherapy for CNS involvement of solid tumorsAspergillus specific nested PCR from the site of infection is superior to testing concurrent blood samples in immunocompromised patients with suspected invasive aspergillosis
P50
Q34602520-9B5A823D-D7F4-4F95-BD79-306670D4BFFDQ37326697-D4068775-C4BE-4C96-97D2-8226083F0A88Q37336198-0416CAAB-B441-4A8F-91A4-79DB0AC33D99Q39691088-B14E70D5-7464-4694-9D55-2F1523B0CD97Q41822618-AC7D1475-4FF5-49EC-B297-DC31A668A58AQ44357778-5E50B487-C72D-4C01-88B8-C9512CC44E02Q52896353-58431A73-3DF7-4534-B4C1-227CEBF02781Q52932396-37A18FA9-AF9E-4019-9CBD-1D70227A7CEEQ52943015-9621D96E-A712-4C17-9224-6CC034AE3F39Q54277258-FE926857-4189-4FAD-A905-096C2D41178FQ54303147-415859BE-5FA1-4CC0-AD22-AA4D9C774D56Q77837407-21D37178-5621-4FB1-A658-BEE5D6A6F56FQ84258158-7EF9C3D5-61F2-4444-804B-D861652074D2Q85185650-7D40E823-2CE9-424F-B00C-E07A1B59C569Q92553309-980A09E2-7438-44B6-AD50-6E93F52014C1
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Mark Reinwald
@ast
Mark Reinwald
@en
Mark Reinwald
@es
Mark Reinwald
@nl
Mark Reinwald
@sl
type
label
Mark Reinwald
@ast
Mark Reinwald
@en
Mark Reinwald
@es
Mark Reinwald
@nl
Mark Reinwald
@sl
prefLabel
Mark Reinwald
@ast
Mark Reinwald
@en
Mark Reinwald
@es
Mark Reinwald
@nl
Mark Reinwald
@sl
P214
P106
P1153
6507144368
P21
P214
P31
P496
0000-0002-6506-2136
P735
P7859
viaf-60224577